Tag: hypothalamic obesity
Setmelanotide shows promise in treating acquired hypothalamic obesity, new trial demonstrates
A randomized controlled trial published in the New England Journal of Medicine demonstrates that setmelanotide, a melanocortin 4 receptor agonist,…
A New Approach to Hypothalamic Obesity: Early Intervention and Weight Management Strategies
Acquired hypothalamic obesity, caused by damage to brain regions controlling hunger and metabolism, requires early identification and multidisciplinary treatment approaches.…
Submit Your Paper to GMJ
No APC until January 2027.